Translating 3D Liver Fibrosis Models into Clinically Relevant Antifibrotic Drug Discovery
Time: 11:30 am
day: Conference Day Two
Details:
- Exploring the benefits of advanced invitro 3D Models for antifibrotic development and prioritization of targets with higher translational potential
- Analysing the antifibrotic effects of VIS08 in animal and in vitro 3D models uncovering novel mechanisms beyond canonical pathways
- Understanding the advantages of novel 3D models beyond MASH in DILI for improved efficacy testing of liver toxicity
